Behind the science
Remission could be possible for people with asthma
We're applying years of expertise in respiratory disease, and a deep understanding of the immune system, to develop solutions that help as many people with asthma as possible achieve clinical remission.
Our purpose
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.Our R&D focus is on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology
Behind the science
Discover how we're getting ahead
‘This could be a golden moment’: Is prevention the ‘medicine’ we need to end the HIV epidemic?
Remission could be possible for people with asthma, giving them a new outlook on life
‘We’ve seen an explosion in computing power’: Using AI, machine learning and data to unlock the mysteries of disease
‘Patients can breathe easier today’: Scientific advances in asthma and COPD care could prevent irreversible lung damage
Advanced technology is increasing the chances of improving outcomes for cancer patients
Robots, AI, and machine learning: how smart manufacturing is getting medicines and vaccines from factories to patients faster
Life at GSK
Find out what it's like to work with us
Make a difference with us
Do your best work with us
Be yourself with us
